Cannabinoids for Symptom Management in Patients with Kidney Failure: A Narrative Review.

Worth, Hayley; O'Hara, Daniel V; Agarwal, Neeru; Collister, David; Brennan, Frank; Smyth, Brendan

Worth, Hayley; O'Hara, Daniel V; Agarwal, Neeru; Collister, David; Brennan, Frank; Smyth, Brendan.

Afiliação

Worth H; Department of Palliative Medicine, St George Hospital, Kogarah, Australia.
O'Hara DV; Kidney Health Division, NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.
Agarwal N; Kidney Health Division, NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.
Collister D; Section of Nephrology, Department of Medicine, University of Alberta, Edmonton, Canada.
Brennan F; Department of Renal Medicine, St George Hospital, Kogarah, Australia.
Smyth B; Kidney Health Division, NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.

Clin J Am Soc Nephrol ; 17(6): 911-921, 2022 06.

Article em En | MEDLINE | ID: mdl-34987023

Assuntos

Canabinoides; Insuficiência Renal; Canabinoides/uso terapêutico; Dronabinol/uso terapêutico; Humanos; Qualidade de Vida; Receptores de Canabinoides; Insuficiência Renal/tratamento farmacológico

Palavras-chave

cannabinoids; chronic kidney failure; pharmacokinetics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canabinoides / Insuficiência Renal Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Clin J Am Soc Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google